Cargando…
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
BACKGROUND: Acute exacerbations contribute to the morbidity and mortality associated with chronic obstructive pulmonary disease (COPD). This proof-of-concept study evaluates whether intermittent pulsed moxifloxacin treatment could reduce the frequency of these exacerbations. METHODS: Stable patients...
Autores principales: | Sethi, Sanjay, Jones, Paul W, Theron, Marlize Schmitt, Miravitlles, Marc, Rubinstein, Ethan, Wedzicha, Jadwiga A, Wilson, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834642/ https://www.ncbi.nlm.nih.gov/pubmed/20109213 http://dx.doi.org/10.1186/1465-9921-11-10 |
Ejemplares similares
-
Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010) -
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007) -
Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008) -
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012) -
Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)